IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 20.098
NA - Nord America 5.052
EU - Europa 2.010
SA - Sud America 1.531
AF - Africa 141
OC - Oceania 71
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 28.907
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.399
US - Stati Uniti d'America 4.749
CN - Cina 2.782
HK - Hong Kong 2.682
BR - Brasile 1.165
GB - Regno Unito 770
VN - Vietnam 679
IT - Italia 365
DE - Germania 241
IN - India 171
AR - Argentina 170
CA - Canada 165
MX - Messico 98
ID - Indonesia 89
NL - Olanda 85
ZA - Sudafrica 78
FI - Finlandia 75
AU - Australia 65
UA - Ucraina 64
JP - Giappone 61
PL - Polonia 58
EC - Ecuador 56
TR - Turchia 45
ES - Italia 42
FR - Francia 40
PY - Paraguay 38
RU - Federazione Russa 38
CZ - Repubblica Ceca 33
SE - Svezia 33
CO - Colombia 32
BD - Bangladesh 29
CL - Cile 25
PE - Perù 22
CH - Svizzera 18
BE - Belgio 17
EE - Estonia 17
LT - Lituania 17
KR - Corea 15
UZ - Uzbekistan 14
SA - Arabia Saudita 13
EG - Egitto 12
MA - Marocco 12
VE - Venezuela 11
AZ - Azerbaigian 10
IL - Israele 9
IQ - Iraq 9
TW - Taiwan 9
UY - Uruguay 9
AT - Austria 8
PH - Filippine 8
PK - Pakistan 8
SI - Slovenia 8
DO - Repubblica Dominicana 7
PT - Portogallo 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
KZ - Kazakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
MD - Moldavia 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CY - Cipro 4
DM - Dominica 4
HN - Honduras 4
IE - Irlanda 4
KH - Cambogia 4
LU - Lussemburgo 4
RS - Serbia 4
DZ - Algeria 3
HR - Croazia 3
JM - Giamaica 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
SY - Repubblica araba siriana 3
AQ - Antartide 2
BF - Burkina Faso 2
BO - Bolivia 2
BZ - Belize 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
IR - Iran 2
JO - Giordania 2
Totale 28.855
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.664
Singapore 1.793
Hefei 1.389
Ashburn 1.298
Boardman 799
London 672
Shanghai 478
Dallas 445
Beijing 437
Ho Chi Minh City 236
Los Angeles 172
San Francisco 164
Hanoi 148
Council Bluffs 137
São Paulo 118
Pune 103
Seattle 102
Munich 95
Toronto 95
Santa Clara 85
New York 72
Washington 66
Rome 62
Warsaw 51
Tokyo 49
Mexico City 48
Amsterdam 44
Rio de Janeiro 44
Turku 40
Brooklyn 39
Johannesburg 37
Helsinki 35
Montreal 35
Melbourne 33
Chicago 32
Haiphong 32
Brno 29
Thái Bình 28
Boston 27
Stockholm 27
Biên Hòa 26
Da Nang 26
Chennai 24
Milan 23
Belo Horizonte 22
Buenos Aires 21
Naples 20
Secaucus 19
Guayaquil 18
Quito 18
Asunción 17
Brasília 17
Phoenix 17
Canberra 16
Lima 16
Sydney 16
West Jordan 16
Ninh Bình 15
Ribeirão Preto 15
Charlotte 14
Tashkent 14
Ankara 13
Campinas 13
Manchester 13
Paris 13
Atlanta 12
Curitiba 12
Hanover 12
Hasselt 12
Porto Alegre 12
St Louis 12
Oklahoma City 11
Salvador 11
San Jose 11
Bắc Giang 10
Caxias do Sul 10
Guangzhou 10
Ha Long 10
Haikou 10
Hải Dương 10
Jakarta 10
Riyadh 10
Sorocaba 10
Viamão 10
Bogotá 9
Boydton 9
Bắc Ninh 9
Goiânia 9
Guarulhos 9
Joinville 9
Santo André 9
The Dalles 9
Camaçari 8
Denver 8
Fortaleza 8
Hortolândia 8
Hyderabad 8
Maceió 8
Manaus 8
Mumbai 8
Totale 13.043
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 231
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 228
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 228
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 219
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 212
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 211
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 210
Designing a broad-spectrum integrative approach for cancer prevention and treatment 210
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 208
Early impairment of food intake in patients newly diagnosed with cancer 205
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 205
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 203
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 201
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 200
A key opinion leader interview with Prof D Santini: insight into cancer research. 199
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 197
Premetastatic niche: ready for new therapeutic interventions? 196
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 195
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 195
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 195
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 195
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 193
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 193
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 193
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 191
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 191
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 187
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 186
Prevention of radiotherapy-induced emesis 186
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 185
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 184
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 184
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 181
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 179
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 179
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 176
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 174
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 172
Docetaxel induced pericardial effusion 167
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 157
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 142
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 126
A giant sarcoma of the parotid gland: A case report and review of the literature 120
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 115
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 115
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 111
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 110
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 110
Anestesia e malattie non comuni 107
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 107
'Old' and 'new' drugs for the treatment of cancer pain 106
Colorectal carcinomas and PTEN/MMAC1 gene mutations 105
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 101
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 101
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 101
Biological effects of cabozantinib on bone microenvironment 101
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 99
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 98
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 97
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 97
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 96
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 96
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 95
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 95
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 94
Idiosyncratic reaction after oxaliplatin infusion 94
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 94
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 94
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 94
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 94
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 94
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 93
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 93
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 93
[Treatment of stage-I seminoma. Critical review] 93
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 93
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 92
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 92
Atypical chronic head and neck pain: don't forget Eagle's syndrome 91
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 90
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 90
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 90
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 89
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 88
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 88
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 88
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 85
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 83
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 82
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 81
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 81
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 79
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 79
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 74
Classic Kaposi Sarcoma: to treat or not to treat? 71
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 69
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 68
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 68
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 67
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 62
Totale 13.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 297.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 297.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/20266.983 1.870 776 1.374 2.466 497 0 0 0 0 0 0 0
Totale 29.042